top of page

Too clever by half

I go through the papers – well The Guardian and Manchester Evening news - day by day, and look for a summary of items of most interest to those of us involved with older people and dementia. This past week there has been news which would wish to excite us and news to accentuate the aches we know we have in body and soul.


A breakthrough? Lecanemab is trumpeted as a breakthrough in the search for a treatment for Alzheimer’s disease: ‘This looks like the real deal’: are we inching closer to a treatment for Alzheimer’s? | Health | The Guardian


But the story has been around for some time. The model depends on belief in the Amyloid Hypothesis. The treatment is complicated – requiring monthly infusions, expensive – not only the cost of the medication itself, but also the equipment to undertake the investigations which are necessary. Side effects have been identified in trials and the benefits are disputed. I thought it had been decided to stop fruitless investment in this approach, to look for alternative models to research and to spend resources on proven methods of care.


Heartbreak: The Leonard Cheshire organisation requires more money to care for its residents with multiple and severe disabilities. Councils cannot afford to pay more because their funding has been brutally reduced. Some residents have to find new homes: Disabled care home residents evicted in charity’s dispute with councils | Social care | The Guardian. The most vulnerable